#drug-pricing — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #drug-pricing, aggregated by home.social.
-
Drug Giant Eli Lilly Shuns Subsidised Medication Listing, Citing Unfair Price
Eli Lilly refused to list its diabetes drug Mounjaro on Australia's PBS because the government's offered price was too low. This affects 450,000 Australians with Type 2 diabetes.
#EliLilly, #Mounjaro, #DiabetesAustralia, #PBS, #DrugPricing
https://newsletter.tf/eli-lilly-refuses-mounjaro-pbs-listing-australia/
-
Eli Lilly's decision means Mounjaro won't be subsidised on Australia's PBS. This affects around 450,000 people with Type 2 diabetes who might not get cheaper access to the drug.
#EliLilly, #Mounjaro, #DiabetesAustralia, #PBS, #DrugPricing
https://newsletter.tf/eli-lilly-refuses-mounjaro-pbs-listing-australia/ -
Toddler Captures Oval Office Spotlight Amid Policy Discussions
A 2-year-old boy's hearing was restored by a Regeneron drug, overshadowing talks on drug costs in the Oval Office on April 23, 2026.
#HearingRestoration, #DrugPricing, #OvalOffice, #Regeneron, #TravisSmith
https://newsletter.tf/toddler-hearing-restored-drug-price-talks/
-
A young child's personal medical success story became the main news, even as the government discussed lowering drug prices.
#HearingRestoration, #DrugPricing, #OvalOffice, #Regeneron, #TravisSmith
https://newsletter.tf/toddler-hearing-restored-drug-price-talks/ -
340B Drug Pricing Program Under Scrutiny: Examining Program Goals and Real-World Effects
The 340B program helps hospitals get cheaper drugs for poor patients. Learn how it works and why it's being discussed.
#340BProgram, #DrugPricing, #HealthcareCosts, #PatientAccess, #HospitalSavings
https://newsletter.tf/340b-drug-program-how-hospitals-get-cheaper-drugs-for-poor-patients/
-
The 340B program helps hospitals get drugs for low-income patients at lower prices. This program is now being looked at closely by the government.
#340BProgram, #DrugPricing, #HealthcareCosts, #PatientAccess, #HospitalSavings
https://newsletter.tf/340b-drug-program-how-hospitals-get-cheaper-drugs-for-poor-patients/
-
Critics Warn TrumpRx Will Further Enrich Big Pharma, Not Reduce Drug Prices
Trump’s son is on the board of a prescription drug platform that may benefit from the direct-to-patient medicine sales. -
TrumpRx launches with big promises on drug prices, but GoodRx is doing the real work
https://fed.brid.gy/r/https://nerds.xyz/2026/02/trumprx-goodrx/
-
As Trump Touts 9 New Prescription Drug Deals, Many Call for Systemic Reform
The ongoing battle over Affordable Care Act subsidies has renewed calls for Medicare for All. -
Big Pharma Is Making Mexico Sick. Medicine and Supply Shortages Are Rampant.
Mexico manufactures medical devices and medicines, but the majority are exported, leaving residents facing shortages. -
A $20 drug in Europe requires a prescription and $800 in the U.S.
https://www.statnews.com/2025/10/31/why-miebo-costs-40-times-more-than-its-european-version/
#HackerNews #drugpricing #prescriptioncosts #healthcare #disparities #Europe #US
-
A $20 drug in Europe requires a prescription and $800 in the U.S.
https://www.statnews.com/2025/10/31/why-miebo-costs-40-times-more-than-its-european-version/
#HackerNews #drugpricing #prescriptioncosts #healthcare #disparities #Europe #US
-
https://www.bbc.com/news/articles/cn0k520v4xro
A bad deal for the UK, as drug prices will be forced up.
Pharmaceutical companies hate the bargaining power that the NHS enjoys because of its centralized purchasing system and will be delighted to see the UK government buckle under the US attack.
The zero tariff agreement - even if the the Trump administration keeps its side of the bargain - will benefit corporations rather than patients.
A bad day for the National Health Service and for the UK as a whole. A bad day for other countries too, as the Trump administration will certainly take this as a sign that bullying works when it comes to drug pricing.🙁
##UKPolitics #UKTrade ##DrugPricing #NHS #NationalHealthService #USUKRelations
-
https://www.bbc.com/news/articles/cn0k520v4xro
A bad deal for the UK, as drug prices will be forced up.
Pharmaceutical companies hate the bargaining power that the NHS enjoys because of its centralized purchasing system and will be delighted to see the UK government buckle under the US attack.
The zero tariff agreement - even if the the Trump administration keeps its side of the bargain - will benefit corporations rather than patients.
A bad day for the National Health Service and for the UK as a whole. A bad day for other countries too, as the Trump administration will certainly take this as a sign that bullying works when it comes to drug pricing.🙁
##UKPolitics #UKTrade ##DrugPricing #NHS #NationalHealthService #USUKRelations
-
Eli Lilly is the first health-care company to hit $1T market value, thanks to its weight-loss drugs. The question now: Is this successful innovation, or proof the US drug pricing system is fundamentally broken for patients?
-
The negotiations were enabled by a law enacted during the Biden administration without any Republican votes.
https://www.nytimes.com/2025/11/25/health/drugs-prices-medicare.html
Prices for Drugs in Medicare’s Second Round of Negotiations
Prices will take effect in 2027.
- Ozempic and Rybelsus, for diabetes, $277; Wegovy, for obesity, $386
- Trelegy Ellipta, for lung conditions, $175
- Xtandi, for prostate cancer, $7,004
- Pomalyst, for blood cancer, $8,650
- Ibrance, for breast cancer, $7,871
- Ofev, for lung conditions, $6,350
- Linzess, for gastrointestinal conditions, $136
- Calquence, for blood cancers, $8,600
- Austedo and Austedo XR, for neurological diseases, $4,093
- Breo Ellipta, for lung conditions, $67
- Tradjenta, for diabetes, $78
- Xifaxan, for liver and gastrointestinal problems, $1,000
- Vraylar, for depression, $770
- Janumet and Janumet XR, for diabetes, $80
- Otezla, for inflammatory conditions, $1,650
-
The negotiations were enabled by a law enacted during the Biden administration without any Republican votes.
https://www.nytimes.com/2025/11/25/health/drugs-prices-medicare.html
Prices for Drugs in Medicare’s Second Round of Negotiations
Prices will take effect in 2027.
- Ozempic and Rybelsus, for diabetes, $277; Wegovy, for obesity, $386
- Trelegy Ellipta, for lung conditions, $175
- Xtandi, for prostate cancer, $7,004
- Pomalyst, for blood cancer, $8,650
- Ibrance, for breast cancer, $7,871
- Ofev, for lung conditions, $6,350
- Linzess, for gastrointestinal conditions, $136
- Calquence, for blood cancers, $8,600
- Austedo and Austedo XR, for neurological diseases, $4,093
- Breo Ellipta, for lung conditions, $67
- Tradjenta, for diabetes, $78
- Xifaxan, for liver and gastrointestinal problems, $1,000
- Vraylar, for depression, $770
- Janumet and Janumet XR, for diabetes, $80
- Otezla, for inflammatory conditions, $1,650
-
Cutting prices on drugs with 5-600%... So either americans will be paid way more than they are paying today to get their drugs, or your president does not understand percentages. He has done this before, so it is not a mistake. Trump can't count. How is this accepted?
-
Cutting prices on drugs with 5-600%... So either americans will be paid way more than they are paying today to get their drugs, or your president does not understand percentages. He has done this before, so it is not a mistake. Trump can't count. How is this accepted?
-
An attempt to import foreign price controls?
Argument: “By undercutting manufacturers’ ability to set #prices for their products, ‘Most Favored Nation’ could reduce access to novel drugs in America, slow innovation & disrupt the market incentives that deliver the low-priced generic drugs that account for the vast majority of prescriptions in this country (the #USA ).
#healthcare #medication #drugs #pharma
~ The #Trump Admin Is Reviving Its Worst #DrugPricing Policies
-
An attempt to import foreign price controls?
Argument: “By undercutting manufacturers’ ability to set #prices for their products, ‘Most Favored Nation’ could reduce access to novel drugs in America, slow innovation & disrupt the market incentives that deliver the low-priced generic drugs that account for the vast majority of prescriptions in this country (the #USA ).
#healthcare #medication #drugs #pharma
~ The #Trump Admin Is Reviving Its Worst #DrugPricing Policies
-
Today in The Medium Newsletter, Anna Dorn shares stories by academics influenced by philosopher #HannahArendt: The Radical Politics of Joy by #philosophy professor Roger Berkowitz, and Speaking in Dark Times by sociologist Elisabeth Becker-Topkara.
Other featured stories discuss #DrugPricing in the U.S., #ProstateCancer testing (in the wake of the diagnosis of former president #JoeBiden), and the recent burning of the #NottowayPlantation in Louisiana.
https://blog.medium.com/joy-is-the-radical-belief-that-the-world-is-worthy-of-love-f81faa24e590
-
Today in The Medium Newsletter, Anna Dorn shares stories by academics influenced by philosopher #HannahArendt: The Radical Politics of Joy by #philosophy professor Roger Berkowitz, and Speaking in Dark Times by sociologist Elisabeth Becker-Topkara.
Other featured stories discuss #DrugPricing in the U.S., #ProstateCancer testing (in the wake of the diagnosis of former president #JoeBiden), and the recent burning of the #NottowayPlantation in Louisiana.
https://blog.medium.com/joy-is-the-radical-belief-that-the-world-is-worthy-of-love-f81faa24e590
-
Tariffs on Pharmaceuticals May Be the Next Front in Trump’s War on Public Health
Trump and his commerce secretary are threatening to make medications more expensive by slapping tariffs on them.
-
Tariffs on Pharmaceuticals May Be the Next Front in Trump’s War on Public Health
Trump and his commerce secretary are threatening to make medications more expensive by slapping tariffs on them.
-
Swedish drug agency’s new pricing model surprises, concerns patient and pharma groups https://www.euractiv.com/section/health-consumers/news/swedish-drug-agencys-new-pricing-model-surprises-concerns-patient-and-pharma-groups/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Sweden
-
Swedish drug agency’s new pricing model surprises, concerns patient and pharma groups https://www.euractiv.com/section/health-consumers/news/swedish-drug-agencys-new-pricing-model-surprises-concerns-patient-and-pharma-groups/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Sweden
-
Dutch trim medicines budget, but cause delayed access to new drugs, says pharma industry https://www.euractiv.com/section/health-consumers/news/dutch-reduced-spend-on-medicines-is-causing-delayed-access-to-new-drugs-says-pharma-industry/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Netherlands
-
Dutch trim medicines budget, but cause delayed access to new drugs, says pharma industry https://www.euractiv.com/section/health-consumers/news/dutch-reduced-spend-on-medicines-is-causing-delayed-access-to-new-drugs-says-pharma-industry/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Netherlands
-
Sweden favours compulsory application for medicines reimbursement in any member state requesting it [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/sweden-favours-compulsory-application-for-medicines-reimbursement-in-any-member-state-requesting-it/?utm_source=dlvr.it&utm_medium=mastodon #drugpricing #EUPharmaPackage #healthcare #Sweden
-
Sweden favours compulsory application for medicines reimbursement in any member state requesting it [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/sweden-favours-compulsory-application-for-medicines-reimbursement-in-any-member-state-requesting-it/?utm_source=dlvr.it&utm_medium=mastodon #drugpricing #EUPharmaPackage #healthcare #Sweden
-
Drug middlemen inflate US prices, squeeze out competition, FTC says - Enlarge / Lina Khan, chair of the Federal Trade Commission (FTC), test... - https://arstechnica.com/?p=2036032 #pharmacybenefitmanagers #expressscripts #cvscaremark #drugpricing #healthcare #science #health #policy #cvs #ftc #pbm
-
Drug middlemen inflate US prices, squeeze out competition, FTC says - Enlarge / Lina Khan, chair of the Federal Trade Commission (FTC), test... - https://arstechnica.com/?p=2036032 #pharmacybenefitmanagers #expressscripts #cvscaremark #drugpricing #healthcare #science #health #policy #cvs #ftc #pbm
-
Big Pharma’s fight against drug price reforms takes weird, desperate turn - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2034140 #medicaredrugpricenegotiations #patentthickets #drugpricing #science #patents #phrma #ip
-
Big Pharma’s fight against drug price reforms takes weird, desperate turn - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2034140 #medicaredrugpricenegotiations #patentthickets #drugpricing #science #patents #phrma #ip
-
Drugmaker to testify on why weight-loss drugs cost 15x more in the US - Enlarge / Lars Fruergaard Jorgensen, chief executive officer Novo Nordi... - https://arstechnica.com/?p=2032005 #pharmaceuticalindustry #berniesanders #drugpricing #novonordisk #weightloss #science #obesity #ozempic #health #wegovy
-
Drugmaker to testify on why weight-loss drugs cost 15x more in the US - Enlarge / Lars Fruergaard Jorgensen, chief executive officer Novo Nordi... - https://arstechnica.com/?p=2032005 #pharmaceuticalindustry #berniesanders #drugpricing #novonordisk #weightloss #science #obesity #ozempic #health #wegovy
-
European Commission opens infringement procedures against Bulgaria over medicine tenders [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/european-commission-opens-infringement-procedures-against-bulgaria-over-medicine-tenders/?utm_source=dlvr.it&utm_medium=mastodon #Bulgaria #drugpricing #EUPharmaPackage
-
European Commission opens infringement procedures against Bulgaria over medicine tenders [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/european-commission-opens-infringement-procedures-against-bulgaria-over-medicine-tenders/?utm_source=dlvr.it&utm_medium=mastodon #Bulgaria #drugpricing #EUPharmaPackage
-
Breaking: Federal judge rules against two drugmakers' "freedom of speech" argument challenging #Medicare drug price negotiation program
https://www.statnews.com/2024/04/29/federal-judge-rules-against-two-drugmakers-challenging-medicare-drug-price-negotiation-program/ via @STAT
-
Breaking: Federal judge rules against two drugmakers' "freedom of speech" argument challenging #Medicare drug price negotiation program
https://www.statnews.com/2024/04/29/federal-judge-rules-against-two-drugmakers-challenging-medicare-drug-price-negotiation-program/ via @STAT
-
Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail—FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal—Novo Nordisk pushes back after price gouging accusations by Bernie Sanders--http://bit.ly/w28kSd #als #amylyx #relyvrio #ftc #bostonscientific #novonordisk #berniesanders #drugpricing #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Medical bills are getting so big Medicare had to add two extra digits on forms - Enlarge (credit: Getty | YinYang)
In a disturbing sign of the ... - https://arstechnica.com/?p=2014290 #pharmaceuticalindustry #cart-celltherapies #drugpricing #medicare #science #health #cms
-
"In a country defined by irrational, runaway drug spending, many gene therapies live on a rare island of semi-rationality: They cost a fortune, but the return, sometimes, is babies who get to have childhoods, grow up and become adults." 🥹
@STAT's Jason Mast on putting a price tag on a miracle...in a world where we already pay a lot of money for other drugs that demonstrably *don't* work:
https://www.statnews.com/2024/03/28/gene-therapy-mld-lenmeldy-orchard-price/
#health #healthcare #genetherapy #medicine #CRISPR #drugpricing #medmastodon
-
Lifesaving gene therapy for kids is world’s priciest drug at $4.25M - Enlarge / A mother with her twin 6-year-old boys who have metachromatic... - https://arstechnica.com/?p=2011685 #metachromaticleukodystrophy #raregeneticconditions #drugpricing #genetherapy #science #orchard #health #fda
-
In oral arguments, drug companies likened leaving #Medicare to giving up an arm.
“A lot of people would say pharmaceutical companies could give up an arm. They have a lot of appendages,” the judge said.
@STAT's Rachel Cohrs summarizes today's drug price negotiation debate:
https://www.statnews.com/2024/03/07/medicare-drug-prices-negotiation-oral-arguments-hearing/
#ira #health #healthcare #medicine #pharma #bigpharma #drugpricing
-
Big Pharma is “coming to the table” on price negotiations as it loses in court - Enlarge (credit: Getty | Bodo Marks)
Federal health officials ... - https://arstechnica.com/?p=2008311 #pharmaceuticalindustry #pricenegotiations #astrazeneca #drugpricing #medicare #science #health #phrma
-
Pharmaceutical issues thread 🧵
(Drug pricing, pharmaceutical pricing, etc.) -
Judge tosses Big Pharma suit claiming drug price negotiation is unconstitutional - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2003073 #pharmaceuticalindustry #astrazeneca #drugpricing #medicare #science #health #phrma
-
Breaking: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices
via @STAT
https://www.statnews.com/2024/02/12/phrma-lawsuit-medicare-negotiate-drug-prices-tossed/#drugpricing #pharma #bigpharma #ira #biotech #health #healthcare #medicine #healthpolicy #Medicare
-
Big Pharma spends billions more on executives and stockholders than on R&D - Enlarge (credit: Senate HELP Committee)
When big pharmaceutica... - https://arstechnica.com/?p=2002556 #pharmaceuticalindustry #researchanddevelopment #bristol-myerssquibb #johnson&johnson #berniesanders #drugpricing #science #patents #merck #pbms
-
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts—Takeda pushes one narcolepsy program into phase III, discontinues another — Moderna shares slide as longer-term data shows quick fall in RSV vaccine efficacy--http://bit.ly/w28kSd #senate #ceos #drugpricing #berniesanders #takeda #clinicaltrials #narcolepsy #moderna #rsv #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Read Bob's @STAT investigation from last year, which was quoted in the suit.
PBMs are paying consultants to refer business to them, which is a conflict of interest that may cost employers who use a consultant to get the the "best" deal on pharmacy benefits:
https://www.statnews.com/2023/06/20/pbms-consulting-firms-investigation/#health #healthcare #medicine #pharma #pbms #bigpharma #drugpricing #healthpolicy #consulting
-
The lone Democrat willing to weaken Medicare’s power to negotiate drug prices...
...received donations from the PACs for:
Gilead
Astellas
Genentech
Bayer
Pfizer
Novo Nordisk
GSK
Bristol Myers Squibb
BIO
Amgen
Boehringer Ingelheim
Merck
AbbVie
Eli Lillyvia @STAT
https://www.statnews.com/2024/02/05/democrat-weaken-medicare-drug-price-negotiation/
#pharma #bigpharma #IRA #drugpricing #health #healthcare #medicine #healthpolicy